| | | RUGULOSIN ((+) FORM)
CAS:23537-16-8
Formula: C30H22O10
>98% by HPLC
BBF-02639
(+)-Rugulosin; Radicalisin; NSC 160880; 5H,13a,5a,14-[1,2,3,4]Butanetetraylcycloocta[1,2-b:5,6-b']dinaphthalene-5,8,13,16(14H)-tetrone, 1,7,9,15,17,20-hexahydroxy-3,11-dimethyl- RUGULOTROSIN A
CAS:685135-81-3
Formula: C32H30O14
>98% by HPLC
BBF-04287
(4R,4'R,4aR,4'AR,7R)-Rel-2,2',3,3',4,4',9,9'-Octahydro-1,1',4,4',8,8'-Hexahydroxy-6,6'-Dimethyl-9,9'-Dioxo-[7,7'-Bi-4aH-Xanthene]-4a,4'A-Dicarboxylic Acid Dimethyl Ester RUPESTONIC ACID
CAS:83161-56-2
Formula: C24H28O8
GëÑ95%
83161-56-2
Rupestonic acid;Pechueloic Acid;83161-56-2;2-[(5R,8S,8aS)-3,8-dimethyl-2-oxo-4,5,6,7,8,8a-hexahydro-1H-azulen-5-yl]prop-2-enoic acid;5-Azuleneacetic acid,1,2,4,5,6,7,8,8a-octahydro-3,8-dimethyl-a-methylene-2-oxo-,[5R-(5a,8a,8ab)]-;115473-63 RUTINOSE
CAS:90-74-4
Formula: C12H22O10
90-74-4
6-O-(Deoxy-a-L-mannopyranosyl)-D-glucose; 6-O-(a-L-Rhamnopyranosyl)-D-glucose; 6-O-(6-Deoxy-+¦-L-mannopyranosyl)-D-glucose; (2R,3S,4R,5R)-2,3,4,5-Tetrahydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)hexanal S-(1, 2, 2-TRICHLOROVINYL)-GLUTATHIONE
CAS:111574-85-7
Formula: C12H16Cl3N3O6S
> 95%
111574-85-7
S-(1,2,2-Trichlorovinyl)glutathione; 111574-85-7; U3MD472OVS; S-(1, 2, 2-Trichlorovinyl)-Glutathione; Glycine, L-g-glutamyl-S-(1,2,2-trichloroethenyl)-L-cysteinyl-; (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-(1,2,2-trichloroetheny S-17092
CAS:176797-26-5
Formula: C22H28N2O2S
98%
176797-26-5
S-17092; S 17092; S17092. [(2S,3aS,7aS)-2-(1,3-thiazolidine-3-carbonyl)-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-[(1R,2R)-2-phenylcyclopropyl]methanone S-ACETYL-PEG3-ACID
CAS:1421933-33-6
Formula: C11H20O6S
GëÑ95%
BP-501625
S-acetyl-PEG3-COOH; S-Acetyl-PEG3-C2-acid; 14-Oxo-4,7,10-trioxa-13-thiapentadecanoic acid; 4,7,10-Trioxa-13-thiapentadecanoic acid, 14-oxo-; 2-Oxo-6,9,12-trioxa-3-thiapentadecan-15-oic acid; 6,9,12-Trioxa-3-thiapentadecan-15-oic acid, 2-oxo S-Deoxo-3,17+¦-bis-(O-tetrahydro-2H-pyran-2-yl)-6-oxo-fulvestrant
CAS:862700-70-7
Formula: C42H61F5O5S
GëÑ95%
862700-70-7
7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfenyl]nonyl]-3,17+¦-bis-(O-tetrahydro-2H-pyran-2-yl)estra-1,3,5(10)-triene-6-one; (17+¦)-7-{9-[(4,4,5,5,5-Pentafluoropentyl)sulfanyl]nonyl}-3,17-bis(tetrahydro-2H-pyran-2-yloxy)estra-1,3,5(10)-trien-6-one S-DEOXO-3,17-BIS-(O-TETRAHYDRO-2H-PYRAN-2-YL)-6-HYDROXY-FULVESTRANT
Formula: C42H63F5O5S
>98%
(7S,8R,9S,13S,14S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-3,17-bis((tetrahydro-2H-pyran-2-yl)oxy)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-6-ol; 7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfenyl]nonyl S-DEOXO-3-KETO-17-ACETOXY FULVESTRANT
CAS:415927-29-6
Formula: C34H51F5O3S
GëÑ95%
415927-29-6
(7+¦,17+¦)-17-(Acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]-estr-4-en-3-one; (7R,8R,9S,10R,13S,14S,17S)-13-Methyl-3-oxo-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopen S-DEOXO-6-OXO-FULVESTRANT
CAS:1107606-70-1
Formula: C32H45F5O3S
GëÑ95%
1107606-70-1
(7+¦,17+¦)-3,17-Dihydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-trien-6-one; Estra-1,3,5(10)-trien-6-one, 3,17-dihydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]-, (7+¦,17+¦)-; (7+¦,17+¦)-3,17-Dihydroxy-7-{9-[(4,4,5 S-DOXAZOSIN-[D8]
CAS:2714418-70-7
Formula: C23H17D8N5O5
>98%
BLP-004207
(S)-(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone; S-Doxazosin D8; 2-{4-[(2S)-2,3-dihydro-1,4-benzodioxine-2-carbonyl](D8)piperazin-1-yl}-6,7-dimethoxyquinazolin-4- S-Me-DM4
CAS:890654-03-2
Formula: C39H56ClN3O10S
BADC-01365
N2'-deacetyl-N2'-[4-methyl-4-(methylthio)-1-oxopentyl]-Maytansine; N2'-Deacetyl-N2'-(4-methyl-4-methylthio-1-oxopentyl)maytansine; (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-a S-METHYL DM1
CAS:912569-84-7
Formula: C36H50ClN3O10S
BADC-01378
N2'-Deacetyl-N2'-[3-(methylthio)-1-oxopropyl]-maytansine; [(1S,2R,3S,5S,6S,16Z,18Z,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18- S-MIRTAZAPINE
CAS:61337-87-9
Formula: C17H19N3
> 95%
61337-87-9
(S)-Org 3770; Esmirtazapine; Org 44-20; S-(+)-Mirtazapine; (S)-1,2,3,4,10,14b-Hexahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine; (+)-Mirtazapine; (14bS)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine S-TERT-BUTYL-L-CYSTEINE HYDROCHLORIDE
CAS:2481-09-6
Formula: C7H15NO2S.HCl
GëÑ95%
BAT-004200
L-Cys(tBu)-OH HCl; L-Cysteine, S-(1,1-dimethylethyl)-, hydrochloride (1:1); L-Cysteine, S-(1,1-dimethylethyl)-, monohydrochloride; Alanine, 3-(tert-butylthio)-, hydrochloride; Alanine, 3-(tert-butylthio)-, hydrochloride, L-; (2R)-2-Amino-3- S-TRIAZINE-1,3,5-TRIETHANOL
CAS:4719-04-4
Formula: C9H21N3O3
0.99
BB054315
s-Triazine-1,3,5-triethanol; 1,3,5-Triazine-1,3,5(2H,4H,6H)-triethanol; 1,3,5-triazine-1,3,5(2h,4h,6h)-triethanol; HEXAHYDRO-1,3,5-TRIS(HYDROXYETHYL)TRIAZINE; HEXAHYDRO-1,3,5-TRIS(2-HYDROXYETHYL)-TRIAZINE S.POMBE LUMAZINE SYNTHASE-IN-1
CAS:331726-35-3
Formula: C14H13N3O6
GëÑ98%
331726-35-3
6-(3,4-dimethoxystyryl)-5-nitropyrimidine-2,4(1H,3H)-dione; 6-[2-(3,4-Dimethoxyphenyl)vinyl]-5-nitro-2,4(1H,3H)-pyrimidinedione; 2,4(1H,3H)-Pyrimidinedione, 6-[2-(3,4-dimethoxyphenyl)ethenyl]-5-nitro- SABARUBICIN
CAS:211100-13-9
Formula: C32H37NO13
>98%
211100-13-9
BMS195615; MEN10755. BMS 195615; MEN 10755. BMS-195615; MEN-10755. (7S,9S)-7-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetra SABUTOCLAX
CAS:1228108-65-3
Formula: C42H40N2O8
>98%
1228108-65-3
BI-97C1; BI 97C1; BI97C1; (1R)-1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-N5,N5'-bis[(2R)-2-phenylpropyl]-[2,2'-binaphthalene]-5,5'-dicarboxamide; (R)-1,1'',6,6'',7,7''-Hexahydroxy-3,3''-dimethyl-N5-((R)-2-phenylpropyl)-N5''-((R)-2-phenylprop Saccharin sodium monohydrate
CAS:171734-71-7
Formula: C7H6NNaO4S
GëÑ95%
171734-71-7
1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide, sodium salt, hydrate (1:1:1); 1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide, sodium salt, monohydrate; Sodium saccharinate monohydrate; Saccharin, sodium salt hydrate; Sodium saccharin hydrate; Sodium SACCHAROCARCIN A
CAS:158475-32-2
Formula: C67H101NO20
>95% by HPLC
BBF-02640
10-[[4-(acetylamino)-2,4,6-trideoxy-3-C-methylhexopyranosyl]oxy]-4-[[O-2,6-dideoxyhexopyranosyl-(1GåÆ4)-O-2,6-dideoxy-3-O-(tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)hexopyranosyl-(1GåÆ4)-2,6-dideoxyhexopyranosyl]oxy]-15-ethyl-2,3,4,4a,6a,9,10 SACCHAROCARCIN B
CAS:158475-33-3
Formula: C68H103NO20
>99% by HPLC
BBF-02641
10-[[4-(acetylamino)-2,4,6-trideoxy-3-C-methylhexopyranosyl]oxy]-4-[[O-2,6-dideoxyhexopyranosyl-(1GåÆ4)-O-2,6-dideoxy-3-O-(tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)hexopyranosyl-(1GåÆ4)-2,6-dideoxyhexopyranosyl]oxy]-2,3,4,4a,6a,9,10,12a,15,1 SACUBITRIL-(2R,4R)-ISOMER
CAS:2259708-00-2
Formula: C24H29NO5
>95%
2259708-00-2
[1,1'-Biphenyl]-4-pentanoic acid, +¦-[(3-carboxy-1-oxopropyl)amino]-+¦-methyl-, 4-ethyl ester, (+¦R,+¦R)-; 4-Ethyl (+¦R,+¦R)-+¦-[(3-carboxy-1-oxopropyl)amino]-+¦-methyl[1,1'-biphenyl]-4-pentanoate; (2R,4R)-Sacubitril; 2R,4R-Sacubitril; 4-(((2R,4R)- SAFFLOR YELLOW A
CAS:85532-77-0
Formula: C27H30O15
85532-77-0
6-+¦-D-Glucopyranosyl-2,3,4,4a,6,9b-hexahydro-3,4,6,7-tetrahydroxy-2-(hydroxymethyl)-8-[3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-9H-pyrano[3,2-b]benzofuran-9-one; 9H-Pyrano[3,2-b]benzofuran-9-one, 6-+¦-D-glucopyranosyl-2,3,4,4a,6,9b-hexahydro SAFFLOWER YELLOW
CAS:36338-96-2
Formula: C43H42O22
GëÑ95%
NP1823
Carthamine; Natural Red 26; Liofresh Red CR; Safflower red;(2R,6Z)-6-({(3Z,5S)-2,5-Dihydroxy-3-[(2E)-1-hydroxy-3-(4-hydroxyphenyl)-2-propen-1-ylidene]-4,6-dioxo-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl] Safinamide metabolite NW-1689 acyl-+¦-D-glucuronide
Formula: C20H19FO9
GëÑ95%
1-[4-[3-(Fluorophenyl)methoxy]benzoate] +¦-D-glucopyranuronic acid; NW-1689 acyl-+¦-D-glucuronide; (2S,3S,4S,5R,6S)-6-{p-[(m-Fluorophenyl)methoxy]benzoyloxy}-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid; (2S,3S,4S,5R,6S)-6-((4-((3-Fl SAFRACIN A
CAS:87578-98-1
Formula: C28H36N4O6
>98%
BBF-02218
Y-16760; 2-Amino-N-[(1-hydroxy-2,11-dimethoxy-3,12,16-trimethyl-10,13-dioxo-6,7,9,10,13,14,14a,15-octahydro-5H-6,15-epiminoisoquinolino[3,2-b][3]benzazocin-9-yl)methyl]propanimidic acid SAFRAMYCIN A
CAS:66082-27-7
Formula: C29H30N4O8
98%
BBF-02840
(-)-saframycin A; 21-Cyanosaframycin-B; N-[[(6S)-7+¦-Cyano-1,5,6,7,9,10,13,14,14a+¦,15-decahydro-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6+¦,15+¦-epimino-4H-isoquino[3,2-b][3]benzazocin-9+¦-yl]methyl]-2-oxopropionamide; Propanamide, SAFRAMYCIN B
CAS:66082-28-8
Formula: C28H31N3O8
BBF-02841
Propanamide, N-((1,5,6,7,9,10,13,14,14a,15-decahydro-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6,15-imino-4H-isoquino(3,2-b)(3)benzazocin-9-yl)methyl)-2-oxo-, (6S-(6-alpha,9-beta,14a-alpha,15-alpha))-; N-[[(6S)-1,5,6,7,9,10,13,14, SAFRAMYCIN C
CAS:66082-29-9
Formula: C29H33N3O9
BBF-02842
Propanamide, N-((1,5,6,7,9,10,13,14,14a,15-decahydro-2,5,11-trimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6,15-imino-4H-isoquino(3,2-b)(3)benzazocin-9-yl)methyl)-2-oxo-, (5S-(5-alpha,6-alpha,9-beta,14a-alpha,15-alpha))-; N-[[(5S)-1,5,6,7, SAFRAMYCIN D
CAS:66082-30-2
Formula: C28H31N3O9
BBF-02843
N-[[(6R)-6,7,9,10,13,14,14a+¦,15-Octahydro-1,4-dihydroxy-2,11-dimethoxy-3,12,16-trimethyl-5,10,13-trioxo-6+¦,15+¦-epimino-5H-isoquino[3,2-b][3]benzazocin-9+¦-yl]methyl]-2-oxopropionamide; Propanamide, N-[[(6R,9R,14aS,15R)-6,7,9,10,13,14,14a,15- SAFRAMYCIN E
CAS:66082-31-3
Formula: C28H33N3O9
BBF-02844
Propanamide, N-[[(5S,6R,9R,14aS,15R)-6,7,9,10,13,14,14a,15-octahydro-1,4,5-trihydroxy-2,11-dimethoxy-3,12,16-trimethyl-10,13-dioxo-6,15-imino-5H-isoquino[3,2-b][3]benzazocin-9-yl]methyl]-2-oxo- SAFRAMYCIN F
CAS:92569-03-4
Formula: C29H30N4O9
BBF-02845
21-Cyanosaframycin D; N-[[(6R)-7+¦-Cyano-6,7,9,10,13,14,14a+¦,15-octahydro-1,4-dihydroxy-2,11-dimethoxy-3,12,16-trimethyl-5,10,13-trioxo-6+¦,15+¦-epimino-5H-isoquino[3,2-b][3]benzazocin-9+¦-yl]methyl]-2-oxopropionamide; Propanamide, N-[[(6R,7R,9 SAFRAMYCIN G
CAS:92569-02-3
Formula: C29H30N4O9
BBF-02846
14-Hydroxysaframycin A; Propanamide, N-[[(5S,6R,7R,9R,14aS,15R)-7-cyano-1,5,6,7,9,10,13,14,14a,15-decahydro-5-hydroxy-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6,15-imino-4H-isoquino[3,2-b][3]benzazocin-9-yl]methyl]-2-oxo-; Propan SAFRAMYCIN H
CAS:92569-01-2
Formula: C32H36N4O9
BBF-02847
25-Dihydro-25-beta-ketopropylsaframycin A; Pentanamide, N-[(7-cyano-1,5,6,7,9,10,13,14,14a,15-decahydro-2,11-dimethoxy-3,12,16-trimethyl-1,4,10,13-tetraoxo-6,15-imino-4H-isoquino[3,2-b][3]benzazocin-9-yl)methyl]-2-hydroxy-2-methyl-4-oxo-, ( SAFRAMYCIN MX1
CAS:113036-78-5
Formula: C29H38N4O9
BBF-02848
Saframycin Mx-1; Propanamide, 2-amino-N-((6,7,9,10,13,14,14a,15-octahydro-1,4,7-trihydroxy-2,5,11-trimethoxy-3,12,16-trimethyl-10,13-dioxo-6,15-imino-5H-isoquino(3,2-b)(3)benzazocin-9-yl)methyl)-, (5S-(5-alpha,6-beta,7-alpha,9-beta(R*),14a- SAFRAMYCIN MX2
CAS:113036-79-6
Formula: C29H38N4O8
BBF-02849
(S)-2-Amino-N-[[[(5S)-6,7,9,10,13,14,14a+¦,15-octahydro-1,4-dihydroxy-2,5+¦,11-trimethoxy-3,12,16-trimethyl-10,13-dioxo-6+¦,15+¦-epimino-5H-isoquino[3,2-b][3]benzazocin]-9+¦-yl]methyl]propionamide; Saframycin Mx-2; Propanamide, 2-amino-N-[[(5S,6 SAGEONE
CAS:142546-15-4
Formula: C19H24O3
97.0%
NP1793
2,3,9,10-Tetrahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylethyl)-4(1H)-phenanthrenone;4(1H)-Phenanthrenone, 2,3,9,10-tetrahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylethyl)- SAGITTATOSIDE A
CAS:118525-35-2
Formula: C33H40O15
>98%
118525-35-2
Sagittatoside A; 118525-35-2; Icariin-A; 3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one; SCHE SAGOPILONE
CAS:305841-29-6
Formula: C30H41NO6S
305841-29-6
DE 03757; DE-03757; DE03757; ZK 219477; ZK219477; ZK-219477; ZK-EPO; (1S,3S,7S,10R,11S,12S,16R)-10-allyl-7,11-dihydroxy-8,8,12,16-tetramethyl-3-(2-methylbenzo[d]thiazol-5-yl)-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione SAIKOGENIN D
CAS:5573-16-0
Formula: C30H48O4
98%
5573-16-0
Saikogenin D; 5573-16-0; (3S,4R,4aR,6aR,6bS,8R,8aS,14aR,14bS)-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicene-3,8-diol; SCHEMBL8156259; CHEMBL3792565 SAIKOSAPONIN B2
CAS:58316-41-9
Formula: C42H68O13
>98%
NP6311
(3b,4a,16a)-16,23,28-Trihydroxyoleana-11,13(18)-dien-3-yl 3-O-b-D-glucopyranosyl-b-D-fucoside; (3+¦,4+¦,16+¦)-16,23,28-Trihydroxyoleana-11,13(18)-dien-3-yl 6-deoxy-3-O-+¦-D-glucopyranosyl-+¦-D-galactopyranoside SAIKOSAPONIN B3
CAS:58316-42-0
Formula: C43H72O14
> 98%
NP7210
+¦-GÇïD-GÇïGalactopyranoside, (3+¦,GÇï4+¦,GÇï11+¦,GÇï16+¦)GÇï-GÇï16,GÇï23,GÇï28-GÇïtrihydroxy-GÇï11-GÇïmethoxyolean-GÇï12-GÇïen-GÇï3-GÇïyl 6-GÇïdeoxy-GÇï3-GÇïO-GÇï+¦-GÇïD-GÇïglucopyranosyl-; (3+¦,4+¦,11+¦,16+¦)-16,23,28-Trihydroxy-11-methoxyolean-12-en-3-yl 6-deoxy-3-O-+¦-D-glucopyranosyl-+¦-D-g SAIKOSAPONIN B4
CAS:58558-09-1
Formula: C43H72O14
> 98%
B0005-479865
+¦-GÇïD-GÇïGalactopyranoside, (3+¦,GÇï4+¦,GÇï11+¦,GÇï16+¦)GÇï-GÇï16,GÇï23,GÇï28-GÇïtrihydroxy-GÇï11-GÇïmethoxyolean-GÇï12-GÇïen-GÇï3-GÇïyl 6-GÇïdeoxy-GÇï3-GÇïO-GÇï+¦-GÇïD-GÇïglucopyranosyl-; (3+¦,4+¦,11+¦,16+¦)-16,23,28-Trihydroxy-11-methoxyolean-12-en-3-yl 6-deoxy-3-O-+¦-D-glucopyranosyl-+¦-D-g SAKYOMICIN A
CAS:86413-75-4
Formula: C25H26O10
BBF-02850
Benz[A]anthracene-1,7,12(2H)-trione, 3,4,4A,12B-tetrahydro-2,3,4A,8-tetrahydroxy-3-methyl-12B-[[2R,5R,6R)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]oxy]-, (2S,3R,4as,12br)-; SKM; (2S)-3,4,4a,12b-Tetrahydro-2+¦,3+¦,4a+¦,8-tetrahydroxy-3-methy SAKYOMICIN B
CAS:86470-27-1
Formula: C19H16O8
BBF-02851
(2S)-3,4,4a,12b-Tetrahydro-2+¦,3+¦,4a+¦,8,12b+¦-pentahydroxy-3-methylbenz[a]anthracene-1,7,12(2H)-trione; Benz(a)anthracene-1,7,12(2H)-trione,3,4,4a,12b-tetrahydro-2,3,4a,8,12b-pentahydroxy-3-methyl-, (2S-(2-alpha,3-beta,4a-alpha,12b-alpha))-; SAKYOMICIN C
CAS:86413-76-5
Formula: C25H26O9
BBF-02852
Benz[a]anthracene-1,7,12(2H)-trione,3,4,4a,12b-tetrahydro-3,4a,8-trihydroxy-3-methyl-12b-[[(2R,5R,6R)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]oxy]-, (3R,4aS,12bR)-; Benz[a]anthracene-1,7,12(2H)-trione,3,4,4a,12b-tetrahydro-3,4a,8-trihyd SAKYOMICIN D
CAS:86413-77-6
Formula: C19H18O8
BBF-02853
Benz[a]anthracene-1,7,12(2H)-trione,3,4,4a,5,6,12b-hexahydro-2,3,4a,8,12b-pentahydroxy-3-methyl-, (2S,3R,4aR,12bR)-; Benz[a]anthracene-1,7,12(2H)-trione,3,4,4a,5,6,12b-hexahydro-2,3,4a,8,12b-pentahydroxy-3-methyl-, [2S-(2a,3b,4aa,12ba)]- SALACINOL
CAS:200399-47-9
Formula: C9H18O9S2
200399-47-9
1,4-Dideoxy-1,4-[(S)-[(2S,3S)-2,4-dihydroxy-3-(sulfooxy)butyl]episulfoniumylidene]-D-arabinitol inner salt; (1S,2R,3S,4S)-1-[(2S,3S)-2,4-Dihydroxy-3-(sulfooxy)butyl]tetrahydro-3,4-dihydroxy-2-(hydroxymethyl)thiophenium inner salt SALASPERMIC ACID
CAS:71247-78-4
Formula: C6H14N2O2
>95%
NP6564
Salaspermic acid;71247-78-4;(3beta,20alpha)-3,24-Epoxy-3-hydroxy-D:A-friedooleanan-29-oic acid;CHEBI:66153;AKOS040762291;LMPR0106150039;HY-127078;CS-0092687;Q27134675;(1R,4S,5R,8S,11R,13R,14S,17R,18S,21S,24R)-21-hydroxy-5,8,11,14,17,24-hexa SALFREDIN B11
CAS:165467-63-0
Formula: C13H12O4
98% by HPLC
BBF-02860
6H-Furo(3,4-g)-1-benzopyran-6-one, 2,8-dihydro-5-hydroxy-2,2-dimethyl-; 2,8-Dihydro-5-hydroxy-2,2-dimethyl-6H-furo(3,4-g)-1-benzopyran-6-one; 9-Hydroxy-6,6-dimethyl-3,6-dihydro-2,5-dioxa-cyclopenta[b]naphthalen-1-one Salmeterol-[d12] Xinafoate Salt
Formula: C36H33D12NO7
BLP-015278
Salmeterol-d12 Xinafoate Salt; 4-(1-Hydroxy-2-((6-(4-phenylbutoxy)hexyl-1,1,2,2,3,3,4,4,5,5,6,6-d12)amino)ethyl)-2-(hydroxymethyl)phenol 1-hydroxy-2-naphthoate SALSOLIDINE HYDROCHLORIDE
CAS:63283-42-1
Formula: C12H18ClNO2
63283-42-1
6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydro-isoquinoline hydrochloride; Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride SALVIPHOLIN
CAS:126724-98-9
Formula: C22H22O7
>95 % (HPLC).
126724-98-9
Spiro[furan-3(2H),7'(8'H)-[1H]naphtho[1,8a-c]furan]-3',9'(6'aH,10'H)-dione,2-(acetyloxy)-5-(3-furanyl)-4,5-dihydro-8'-methyl-, (2R,3S,5S,6'aR,8'S,10'aS)-(9CI) SAMIDORPHAN
CAS:852626-89-2
Formula: C21H26N2O4
GëÑ95%
852626-89-2
ALKS 33; 17-(Cyclopropylmethyl)-4,14-dihydroxy-6-oxomorphinan-3-carboxamide; (4bR,8aS,9R)-11-(cyclopropylmethyl)-4,8a-dihydroxy-6-oxo-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene-3-carboxamide; Morphinan-3-carboxamide, 17-(cy Samidorphan hydrochloride
CAS:2328045-02-7
Formula: C21H27ClN2O4
GëÑ95%
2328045-02-7
ALKS 33 hydrochloride; Samidorphan HCl; (4bR,8aS,9R)-11-(Cyclopropylmethyl)-4,8a-dihydroxy-6-oxo-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene-3-carboxamide hydrochloride; RDC 0313-00 hydrochloride; 17-(Cyclopropylmethyl)-4,14 Samidorphan-[d4]
Formula: C21H22D4N2O4
BLP-015279
Samidorphan-d4; (4bR,8aS,9R)-11-((Cyclopropyl-2,2,3,3-d4)methyl)-4,8a-dihydroxy-6-oxo-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene-3-carboxamide SANCYCLINE
CAS:808-26-4
Formula: C21H22N2O7
>95%
BBF-03881
Minocycline EP Impurity B; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Norcycline; Bonomycin SANCYCLINE HYDROCHLORIDE
CAS:6625-20-3
Formula: C21H23ClN2O7
>98% by HPLC
BBF-04443
6-Demethyl-6-deoxytetracycline hydrochloride; NSC 51812; (4S,4aS,5aR,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1-11-dioxo-2-naphthacenecarboxamide Hydrochloride; Bonomycin; Norcycline; GS 2147; Minocycl SANDRAMYCIN
CAS:100940-65-6
Formula: C60H76N12O16
GëÑ95%
100940-65-6
(-)-Sandramycin; 3-Hydroxy-N-[23-[(3-hydroxyquinoline-2-carbonyl)amino]-8,11,28,31-tetramethyl-2,6,9,12,15,22,26,29,32,35-decaoxo-7,27-di(propan-2-yl)-5,25-dioxa-1,8,11,14,21,28,31,34-octazatricyclo[34.4.0.016,21]tetracontan-3-yl]quinoline- SANGLIFEHRIN A
CAS:187148-13-6
Formula: C60H91N5O13
BBF-02863
SFA; (-)-sanglifehrin A; 19-Oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone, 18-[(1E,3E,7S,8S)-9-[(2S,3R,4S,5S,6R,9S,11S)-9-ethyl-4-hydroxy-3,5,11-trimethyl-8-oxo-1-oxa-7-azaspiro[5.5]undec-2-yl]-8-hydroxy-1,7-dim SANNAMYCIN G
CAS:73522-72-2
Formula: C14H30N4O4
BBF-02871
2-Amino-1,2,5-trideoxy-3-O-(2,6-diamino-2,3,4,6-tetradeoxy-+¦-D-erythro-hexopyranosyl)-6-O-methyl-5-(methylamino)-D-chiro-inositol; Antibiotic KA-7038V; Istamycin X0; KA-7038V; D-Chiro-inositol, 2-amino-1,2,5-trideoxy-3-o-(2,6-diamino-2,3,4, SANNAMYCIN H
CAS:73491-61-9
Formula: C14H30N4O4
BBF-02872
Istamycin Y0; 3-Amino-2,3,6-trideoxy-4-O-(2,6-diamino-2,3,4,6-tetradeoxy-+¦-D-erythro-hexopyranosyl)-1-O-methyl-6-(methylamino)-D-myo-inositol; Antibiotic KA-7038VII; KA-7038VII; D-myo-Inositol, 3-amino-2,3,6-trideoxy-4-O-(2,6-diamino-2,3,4, SANTIN
CAS:27782-63-4
Formula: C18H16O7
GëÑ95%
BBF-05115
2-(4-Methoxyphenyl)-5,7-dihydroxy-3,6-dimethoxy-4H-1-benzopyran-4-one; 3,4',6-Trimethoxy-5,7-dihydroxyflavone; 5,7-Dihydroxy-3,6,4'-trimethoxyflavone; 6-Hydroxykaempferol 3,4',6-trimethyl ether; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-3,6-dime SAPONARIN
CAS:20310-89-8
Formula: C27H30O15
>98%
NP2000
Saponaretin-7-O-glucoside; Isovitexin-7-O-glucoside; Isovitexin-7-O-beta-D-glucopyranoside; 5-hydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-7-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl SAPROPTERIN RELATED COMPOUND ((6S)-5,6,7,8-TETRAHYDRO-L-BIOPTERIN SULFATE)
CAS:109784-74-9
Formula: C9H15N5O3.xH2SO4
GëÑ95%
109784-74-9
4(1H)-Pteridinone, 2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-, [6S-[6R*(1S*,2R*)]]-, sulfate (1:x) (salt); (S)-2-Amino-6-((1R,2S)-1,2-dihydroxypropyl)-5,6,7,8-tetrahydropteridin-4(1H)-one sulfate (1:x); (6S)-5,6,7,8-Tetrahydro-L-er SAQUAYAMYCIN A
CAS:99260-65-8
Formula: C43H48O16
BBF-02878
saquayamycin; Benz[a]anthracene-1,7,12(2H)-trione, 9-[2,6-dideoxy-4-O-[(2R,6S)-5,6-dihydro-6-methyl-5-oxo-2H-pyran-2-yl]-b-D-arabino-hexopyranosyl]-3-[[(2S,5S,6S)-5-[[(2R,6S)-5,6-dihydro-6-methyl-5-oxo-2H-pyran-2-yl]oxy]tetrahydro-6-methyl- SAQUAYAMYCIN A1
CAS:99260-66-9
Formula: C31H32O12
95%
BBF-03451
Benz[a]anthracene-1,7,12(2H)-trione, 9-[2,6-dideoxy-4-O-[(2R,6S)-5,6-dihydro-6-methyl-5-oxo-2H-pyran-2-yl]-+ó-Darabino-hexopyranosyl]-3,4,4a,12b-tetrahydro-3,4a,8,12b-tetrahydroxy-3-methyl-, (3R,4aR,12bS)-; (3R)-9-[4-O-[(2R,6S)-5,6-Dihydro-6 SAQUAYAMYCIN B
CAS:99260-67-0
Formula: C43H48O16
BBF-02879
Benz[a]anthracene-1,7,12(2H)-trione, 9-[[2',3-anhydro]-2,6-dideoxy-4-O-(3,6-dideoxy-a-L-erythro-hexopyranos-4-ulos-1-yl)-b-D-arabino-hexopyranosyl]-3-[[(2S,5S,6S)-5-[[(2R,6S)-5,6-dihydro-6-methyl-5-oxo-2H-pyran-2-yl]oxy]tetrahydro-6-methyl- SAQUAYAMYCIN B1
CAS:99260-68-1
Formula: C31H32O12
GëÑ95%
BBF-02882
Benz[a]anthracene-1,7,12(2H)-trione, 9-[[2',3-anhydro]-2,6-dideoxy-4-O-(3,6-dideoxy-RL-erythro-hexopyranos-4-ulos-1-yl)-a-Darabino-hexopyranosyl]-3,4,4a,12b-tetrahydro-3,4a,8,12b-tetrahydroxy-3-methyl-, (3R,4aR,12bS)- SAQUAYAMYCIN C
CAS:99260-70-5
Formula: C43H52O16
BBF-02880
Benz[a]anthracene-1,7,12(2H)-trione, 9-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-b-D-arabino-hexopyranosyl]-3,4,4a,12b-tetrahydro-4a,8,12b-trihydroxy-3-methyl-3-[[(2S,5S,6S)-tetrahydro-6-methyl-5-[[(2R,6S)-tetrahydr SAQUAYAMYCIN C1
CAS:99260-69-2
Formula: C31H34O12
BBF-02883
(3R)-9-[4-O-[(2R,6S)-Tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-2,6-dideoxy-+¦-D-arabino-hexopyranosyl]-3,4,4a,12b-tetrahydro-3+¦,4a+¦,8,12b+¦-tetrahydroxy-3-methylbenz[a]anthracene-1,7,12(2H)-trione SAQUAYAMYCIN D
CAS:99260-71-6
Formula: C43H50O16
BBF-02881
Benz[a]anthracene-1,7,12(2H)-trione, 9-[[2',3-anhydro]-2,6-dideoxy-4-O-(3,6-dideoxy-a-L-erythro-hexopyranos-4-ulos-1-yl)-b-D-arabino-hexopyranosyl]-3,4,4a,12b-tetrahydro-4a,8,12b-trihydroxy-3-methyl-3-[[(2S,5S,6S)-tetrahydro-6-methyl-5-[[(2 SAQUINAVIR EP IMPURITY C
CAS:136522-17-3
Formula: C24H39N3O2
GëÑ95%
136522-17-3
(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-(1,1-dimethylethyl)decahydroisoquinoline-3-carboxamide; 3-Isoquinolinecarboxamide, 2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-(1,1-dimethylethyl)decahydro-, (3S,4aS,8aS)-; (3S,4a SARCANDROLIDE D
CAS:1207185-03-2
Formula: C37H42O12
>96%
NP5652
2-Butenoic acid, 2-methyl-, [(1aR,1bS,2R,2aS,5cR,9aR,10S,10aS,11aR,11bS,11cS,12aS,12bS)-8-[(acetyloxy)methyl]-1,1a,1b,2,2a,4,7,9,9a,10,10a,11,11a,11b,11c,12,12a,12b-octadecahydro-1,2a,10,12a-tetrahydroxy-1b,5,11b-trimethyl-4,7-dioxobiscyclo SARECYCLINE-D6 HYDROCHLORIDE
Formula: C24H30ClD6N3O8
BB056784
(4S,4aS,5aR,12aS)-4-(Dimethylamino)-3,10,12,12a-tetrahydroxy-7-(((methoxy-d3)(methyl-d3)amino)methyl)-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide Hydrochloride SARICANDIN
CAS:178494-90-1
Formula: C44H54O16
BBF-02884
+ó-D-Galactopyranoside, (1S,3'R,4'R,5'R,6'R)-3',4',5',6'-tetrahydro-3',5,7-trihydroxy-6'-(hydroxymethyl)-4'-[[(2E,4E,8E,10E)-7-hydroxy-1-oxo-2,4,8,10-hexadecatetraenyl]oxy]-spiro[isobenzofuran-1(3H),2'-[2H]pyran]-5'-yl,6-[(2E)-3-phenyl-2-pro SARMENTINE-[D8]
CAS:1795136-21-8
Formula: C14H15D8NO
BLP-004199
(2E,4E)-1-(1-Pyrrolidinyl-d8)-2,4-decadien-1-one; (E,E)-1-(1-Oxo-2,4-decadienyl)pyrrolidine-d8; 1-[(2E,4E)-1-Oxo-2,4-decadienyl]pyrrolidine-d8; 1-[(E,E)-2,4-Decadienoyl]pyrrolidine-d8; 2,4-(E,E)-Decadienoylpyrrolidide-d8; Iyeremide A-d8 SARMENTOCYMARIN
CAS:98633-61-5
Formula: C30H46O8
98.0%
NP6229
Sarmentogenin 3-O-sarmentoside; 3-[(3S,5R,8R,9S,10S,11R,13R,14S,17R)-11,14-dihydroxy-3-[(2R,4S,5S,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H |
